Patrick F. Smith, PRESIDENT, DRUG Development SOLUTIONS at Certara, Inc. (CERT), sold 10,818 shares at $11.03 ($119K) on 2024-10-07, disclosed to the SEC on 2024-10-08.
Scheduled sale ($119k) by PRESIDENT, DRUG Development SOLUTIONS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.03 | 5,409 | $60K | 50.0% |
| 2 | $11.03 | 5,409 | $60K | 50.0% |
| Total | $11.03 avg | 10,818 | $119K | 100% |
| Filing → |
| CERT | SELL | 2023-06-06 | $823K | — | Filing → |
| CERT | SELL | 2022-11-14 | $32K | — | Filing → |
| CERT | SELL | 2022-08-18 | $177K | — | Filing → |